Clinical Trial Update: Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating Velcade (bortezomib) in combination with other drugs for previously untreated multiple myeloma has completed and results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Velcade (bortezomib)

Snippet

Sponsor: Millennium Pharmaceuticals, Inc. | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-12-29